Editas Medicine, Inc. (EDIT)
2.56
-0.04
(-1.54%)
USD |
NASDAQ |
Dec 11, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Research and Development Expense (TTM): 105.31M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 3.776M |
| Arcutis Biotherapeutics, Inc. | 71.08M |
| Daré Bioscience, Inc. | 6.616M |
| Cogent Biosciences, Inc. | 251.67M |
| Janux Therapeutics, Inc. | 115.15M |